|
Current issue
Archive
Videos
Articles in press
About the journal
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Supplements
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
|
abstract:
Review paper
Ocular manifestations of COVID-19: a systematic and narrative literature review
Oliwia Sędziak
1
,
Hanna Pietruszewska
2
,
Natalia Kruszewska
3
,
Urszula Borucińska
4
,
Sabina Skrzynecka
5
KLINIKA OCZNA 2026, 128, 2:
Online publish date: 2026/04/27
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, presents with a broad clinical spectrum extending beyond respiratory symptoms to include ocular manifestations. Increasing evidence indicates that the virus may affect the ocular surface, leading primarily to conjunctivitis, tearing, itching, and dry eye, while in rarer cases causing retinal and neuro-ophthalmic complications. The expression of angiotensin-
converting enzyme 2, transmembrane protease serine 2, and CD147 receptors in ocular tissues supports the hypothesis of direct viral tropism and possible transmission via conjunctival secretions. A review of 62 studies published between 2020 and 2025 including original research, meta-analyses, systematic reviews, and case reports revealed that ocular symptoms occur in approximately 5–20% of COVID-19 patients. Retinal microangiopathy, vascular occlusions, and optic nerve neuropathies were less frequent but clinically significant. In certain cases, ocular signs were the first or sole manifestation of infection. Although relatively uncommon, ocular involvement in COVID-19 carries diagnostic and epidemiological importance, emphasizing the need for ophthalmologic vigilance and further prospective studies to elucidate underlying mechanisms, prevalence, and long-term consequences. keywords:
COVID-19, SARS-CoV-2, conjunctivitis, eye diseases, vaccination, post-acute COVID-19 syndrome |
 |
POLSKI
